Clinical trial Recruiting at 3 sites Interventional Ages 22 to 75

Connexus® Brain-Computer Interface to restore communication and device control

Official title: Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) to Provide Human Connection Through Communication

Run by Paradromics · NCT07357428 · Data updated 2026-11-12

This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.

Quick facts

Study typeInterventional
Ages22 Years to 75 Years
SexAll
Enrollment2 (estimated)
SponsorParadromics
Industry-sponsored
Locations3 sites (Sacramento, California and 2 other locations)
StatusRecruiting
StartedMarch 31, 2026
Main results expectedMay 2027
Study endsJanuary 2032
Registry record updatedApril 14, 2026
Trial IDNCT07357428 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with progressive neuromuscular disease or neurological injury who have anarthria or severe dysarthria, are wheelchair dependent with minimal upper-limb function, can communicate reliably in English, have a study care partner, and live within about four hours of a study site.

Probably not a fit

Patients who retain usable speech or hand function, who have cognitive impairment or psychiatric conditions that prevent participation, who have incompatible implanted devices, who require frequent MRIs, or who live far from a study center are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Connect-One early feasibility study uses the Connexus brain-computer interface to decode imagined language correlates and speech and to translate neural signals into commands for computer control in people with severe loss of voluntary motor control. Participants will be enrolled at sites in Sacramento (UC Davis), Boston (Massachusetts General Hospital), and Ann Arbor (University of Michigan) and followed to collect preliminary device safety and performance data. Eligible participants are typically anarthric or have severe dysarthria, are wheelchair dependent with severely impaired upper limb function, can read and understand English, and have a study care partner and local access to a study site. Key exclusions include cognitive or psychiatric impairments that prevent compliance, other implanted devices (e.g., pacemaker, DBS), the need for regular MRIs, or other medical conditions that would interfere with participation.

Why it matters

Potential benefit: If successful, the device could restore or substantially improve communication and allow computer control for people with severe motor and speech impairments.

How similar studies have gone: Related intracortical and brain-computer interface programs have demonstrated proof-of-concept successes in decoding intended movements and limited speech signals, but translating those results into routine, natural speech restoration remains experimental.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of a progressive neuromuscular disease or a neurological injury.
* Clinical diagnosis of anarthria or severe dysarthria.
* Wheelchair dependent with severely impaired upper limb function.
* Has a reliable method of communication and the ability to read and understand the English language.
* Has a study care partner (e.g. caregiver or multiple caregivers) for the duration of the study.
* Lives within a 4-hour radius of a study site.

Exclusion Criteria:

* Cognitive impairment or psychiatric illness that could impact the ability to comply with study requirements, as determined by the Study Investigator.
* Co-morbidities or an ongoing chronic medical condition that would impair the ability to comply with study requirements.
* The presence of another implanted device, like a pacemaker, deep brain stimulator, or implantable pulse generator.
* Requires, or is expected to require regular MRI scans for on-going medical conditions.
* In the opinion of the Study Investigator, the patient is not an appropriate candidate for the study, for reasons that could place the patient at undue risk or otherwise result in non-compliance with the study requirements.

Where it's running

  • University of California, Davis
    Sacramento, California, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.